期刊文献+

早期和晚期肺腺癌的差异基因和信号通路富集分析 被引量:5

An Analysis of Differential Expression Genes and Gene Sets Associated with Lung Adenocarcinoma in Early and Advanced Lung Adenocarcinoma
原文传递
导出
摘要 [目的]分析早期和晚期肺腺癌的差异基因和信号通路。[方法]从美国国立生物信息中心(NCBI)的GEO数据库下载GSE10072数据集,去除临床指标缺失的样本,按照TNM分期将肺腺癌样本分为早期(Ⅰ期.共16例)和晚期(Ⅲ-Ⅳ期,共15例)两组。原始数据经dChip进行质量检验、标准化,然后进行差异基因分析。从MsigDB数据库获得344个生物信号基因集,通过GSEA进行信号通路富集分析,[结果]获得SEMA3、PLAU、CDKN2A等14个明显差异基因,获取的差异基因主要与细胞凋亡、细胞黏附等过程密切相关。选取MsigDB中来源于Bicarta、KEGG、GenMAPP三大数据库的344个基因集进行富集分析,结果发现Death pathway、Leukocyte transemtothelial migration和Focaladhesion等22条信号通路在晚期肺腺癌中明显富集.富集通路主要涉及细胞凋亡、细胞黏附和迁移等过程。[结论]早期与晚期肺癌中存在一些明显的差异表达基因,有部分信号通路在晚期肺腺癌中明显富集。 { Purpose] To analyze the differential expression genes and gene sets associated with lung adeno- carcinoma in early and advanced lung adenocarcinoma. [Methods] l,ung adenocarcinnma gene expression profile data GSE10072 were obtained from Gene Expression Omnibus (GEO) database of National Center for Biotechnology Informalion. Samples without clinical data were excluded. The samples were divided into early stage group (stage Ⅰ , 16 samples) and advanced stage grnup (stage Ⅲand Ⅳ, 15 samples). Raw data were normalized,quality control and analyses of differentially expressed genes by dChip software. Three hundred and forty-four gene sets of cell signal pathways from MsigDB bank.The enrichment of gene sets was analyzed bv GSEA software. [Results] Fourteen differentially expressed genes including SEMA3,PLAU, CDKN2A were obtained by dChip analysis. Data mining showed that differentially expressed genes obtained were related with developmental programmed cell death,cell adhesion. Analysis of gene sets enrichment against 344 pathways from Bicarta,KEGG,GenMAPP,showed that three pathways including Death pathway, Leukocyte transendothelial migration and Foeal adhesion were enriched in advanced lung adenocarcinoma. [Conclusion] There are some differential expression genes between early aud advanced hmg adenocarcinoma,and some pathways are enriching in advanced hmg adenneareinnma.
出处 《中国肿瘤》 CAS 2013年第1期54-58,共5页 China Cancer
基金 广东省自然科学基金项目(S2011010004147) 广州医学院2011年科研基金博士启动基金(2011C06)
关键词 肺腺癌 表达谱 基因通路 基因富集 lung adenocareinoma gene expression profile signal pathway GSEA
作者简介 通讯作者:王桂平,E-mail:docgpwang@yahoo.com.cn
  • 相关文献

参考文献15

  • 1Parkin DM,Bray F,Ferlay J. Global cancer statistics,2002[J].CA:A Cancer Journal for Clinicians,2005,(02):74-108.
  • 2杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 3Soon YY,Stockler MR,Askie LM. Duration of chemotherapy for advanced non-small-cell lung cancer:a systematic review and meta-analysis of randomized trials[J].Journal of Clinical Oncology,2009,(20):3277-3283.
  • 4Krepela E,Dankova P,Moravcikova E. Increased expression of inhibitor of apoptosis proteins,survivin and XIAP,in non-small cell lung carcinoma[J].International Journal of Oncology,2009,(06):1449-1462.
  • 5Talbot SG,Estilo C,Maghami E. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung[J].Cancer Research,2005,(08):3063-3071.
  • 6Glinsky GV,Glinskii AB,Stephenson AJ. Gene expression profiling predicts clinical outcome of prostate cancer[J].Journal of Clinical Investigation,2004,(06):913-923.
  • 7Korrat A,Greiner T,Maurer M. Gene signature-based prediction of tumor response to cyclophosphamide[J].Cancer Genomics Proteomics,2007,(03):187-195.
  • 8Amin SB,Shah PK,Yan A. The dChip survival analysis module for microarray data[J].BMC Bioinformatics,2011.72.
  • 9王桂平,叶云,杨晓勤,陈新美,梁爽,郑文岭,马文丽.基于基因表达谱的途径筛选肺腺癌治疗药物[J].中国临床药理学与治疗学,2010,15(3):266-272. 被引量:5
  • 10Irizarry RA,Wang C,Zhou Y. Gene set enrichment analysis made simple[J].Statistical Methods in Medical Research,2009,(06):565-575.doi:10.1177/0962280209351908.

二级参考文献26

  • 1杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 2李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Jensen OM, Esteve J, Moller H, et al. Cancer in the European Community and its member states. Eur J Cancer, 1990, 26(11-12): 1167-1256. Erratum in: Eur J Cancer, 1991,27 (12):1717.
  • 5European Network of Cancer Registries (ENCR). (2001) EURO CIM version 4. 0. European Incidence Database V2. 3. Lyon:IARC Press,2001.
  • 6Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer,2002,38(1): 99-166.
  • 7Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005,14(1): 243-250.
  • 8International Agency for Research on Cancer. IARC monographs on the Tobacco Smoke and Involuntary Smoking (Vol. 83). Lyon:IARC Press,2004.
  • 9Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ,1998,317(7170) : 1411-1422.
  • 10Clinical Trial Service Unit, Oxford University. Emerging Tobacco Hazards in China. http:∥rum. ctsu. ox. ac. uk/tobacco.

共引文献171

同被引文献45

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部